mail
versión imprimible
 
 

5th Gene Therapy Immunogenicity Summit 2024

Hanson Wade
-
20.08.2024 - 22.08.2024  The Westin Boston Seaport District, 425 Summer Street, 02210 Boston, Massachusetts, USA
Time: 8:30 AM - 4:00 PM
 
Temas de la conferencia
The success of gene therapy hinges on overcoming the immunogenicity challenges of viral vectors. With more viral vector-based gene therapies progressing through the pipeline, we need to seek solutions to this critical bottleneck 'here and now'.
La Sociedad Científica
Evvnt Promotion / evvnt
Observaciones
URL:
Brochure: https://go.evvnt.com/2453359-0?pid=4832

Speakers: Alison Johnson | Principal Scientist | Boehringer Ingelheim, Bala Medicherla | Head, Bioanalytics | Astellas Gene Therapies, and more
 

Información e inscripción:

https://go.evvnt.com/2453359-2?pid=4832
 
Categorías
Medicina General
Idioma
Inglés
Cuota del Congreso
USD 2599.00 - USD 5097.00
Cantacto organizador
83 Great Titchfield Street
W1W 6RH London
United Kingdom
 
"Going International fomenta el acceso a la educación y a la formación continua independientemente de fronteras sociales, geográficas y nacionales."

Anästhesie in Entwicklungsländern e. V.Österreichische Gesellschaft für Public HealthnewTreeSwiss Tropical and Public Health InstituteÄrzte der WeltAMREF - African Medical and Research FoundationEuropean Public Health Association (EUPHA)Hilfswerk Austria